Home > Press > Advanced Magnetics, Inc. to Present at the Bear Stearns Biotech Confab
Advanced Magnetics, Inc. (Nasdaq: AMAG) today announced that it will participate in the Bear Stearns Biotech Confab being held June 7, 2007 at the Boston Marriott Copley Place, Boston, MA. Brian J.G. Pereira, MD, President and CEO of Advanced Magnetics, will present an overview of the company at 10:40 am ET.
Advanced Magnetics, Inc. to Present at the Bear Stearns Biotech Confab
Cambridge, MA | Posted on May 29th, 2007
A live webcast of this presentation will be accessible through the
Investors section of the company's website at http://www.advancedmagnetics.com .
Following the conference, the webcast will be archived on the Advanced
Magnetics website until July 7, 2007.
About Advanced Magnetics, Inc.
Advanced Magnetics, Inc. is a biopharmaceutical company that utilizes
its proprietary nanoparticle technology for the development and
commercialization of therapeutic iron compounds to treat anemia and novel
imaging agents to aid in the diagnosis of cancer and cardiovascular
Ferumoxytol, the company's key product candidate, is being developed
for use as an intravenous iron replacement therapeutic for the treatment of
iron deficiency anemia in chronic kidney disease. The company has completed
enrollment in four Phase III clinical trials with ferumoxytol and has
presented data on three of the four trials.
Combidex, the company's other product under development, is an
investigational functional molecular imaging agent consisting of iron oxide
nanoparticles for use in conjunction with magnetic resonance imaging (MRI)
to aid in the differentiation of cancerous from normal lymph nodes. In
March 2005, the company received an approvable letter from the FDA with
respect to Combidex, subject to certain conditions.
The company has two commercial products, Feridex I.V.(R) and
GastroMARK(R), both of which are imaging agents that are approved and
marketed in the United States, Europe and other countries.
For more information, please click here
Senior Director, Investor Relations
125 CambridgePark Drive
Cambridge, MA 02140
(617) 499-3361 (fax)
61 Mooney St.
Cambridge, MA 02138
(617) 547-2445 (fax)
Copyright © PR Newswire Association LLC.
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
MANA Research Highlight: Smart nanofibers to treat kidney failure March 6th, 2014
Harris & Harris Group, Inc. Establishes and Invests $350,001 in ProMuc, Inc. March 6th, 2014
First Look at How Individual Staphylococcus Cells Adhere to Nanostructures Could Lead to New Ways to Thwart Infections: Berkeley Lab-led research could guide the development of bacteria-resistant materials March 5th, 2014
Dartmouth Researchers Find Promising Results with Local Hyperthermia of Tumors March 4th, 2014
Nanopositioning Stage & Digital Controller for Imaging, Surface Metrology and Microscopy Available from PI March 6th, 2014
Elmarco Enabled Industrial Electrospinning Technology for Laboratories: Elmarco introduces NS LAB, the electrospinning research tool designed for the needs of universities and research institutes March 6th, 2014
New Data Model Boosts Space Science March 6th, 2014
Carbodeon NanoDiamonds PTFE Coating doubles surface durability and reduces friction by up to 66 percent: New surface coating enables cost-effective CO2 and fuel reductions in machinery March 6th, 2014
Singapore's A*STAR IME will present 9 papers in optical device innovation and foundry-qualified platform development at world-class optical communications conference March 6th, 2014
How 19th Century Physics Could Change the Future of Nanotechnology: University of Cincinnati physics researchers have developed a new way of using an old technique that could help build better nanotechnology March 5th, 2014
Malvern Instruments announces guest presenter for March 18th protein characterization webinar: Renowned protein scientist Prof. Dr. John F. Carpenter shows how combining Dynamic Light Scattering with Raman Spectroscopy delivers new insights in protein stability, aggregation... March 4th, 2014
UC research tests which nano system works best in killing cancer cells: New UC research to be presented this week tested four iron-oxide nanoparticle systems to see which, when heated, would likely work best as a tool for targeting cancer cells March 4th, 2014